Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.72 USD | +0.99% | +3.56% | -36.29% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.29% | 817M | |
-1.93% | 103B | |
+0.49% | 95.71B | |
+1.69% | 22.02B | |
-17.39% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.94% | 15.52B | |
+3.51% | 13.86B | |
+35.07% | 12.04B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- SVB Securities Adjusts Sage Therapeutics' Price Target to $40 from $50, Keeps Market Perform Rating